Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Haddad
Robert
R
Posner
Marshall
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000601:surgery; D017322:Clinical Trials, Phase II as Topic; D003627:Data Interpretation, Statistical; D023381:Endpoint Determination; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D015080:Mesna / Q000008:administration & dosage; D009503:Neutropenia / Q000139:chemically induced*; D017239:Paclitaxel / Q000008:administration & dosage; D015203:Reproducibility of Results; D013534:Survival; D043823:Taxoids
D043823:Taxoids; D016190:Carboplatin; D015080:Mesna; D017239:Paclitaxel; D007069:Ifosfamide